HOUSE-BILL 8651: H.R.8651 - Advancing Safe Medications for Moms and Babies Act of 2026
AI-Powered Summary
HOUSE-BILL 8651 aims to enhance the inclusion of pregnant and lactating women in clinical research, addressing significant gaps in medical studies that often overlook this vulnerable population. The legislation emphasizes the constitutional rights of individuals, particularly the right to health care, informed consent, and participation in research. It empowers the Secretary of Health and Human Services to create regulations that align with existing protections for pregnant women in research settings. Key provisions include mandated updates to FDA regulations to facilitate the participation of pregnant women in clinical trials, the establishment of an education campaign to inform them about their rights and options in research, and the creation of a prioritization process for research focused on drugs affecting this demographic. Implementation of these provisions will require regulatory updates and the launch of educational initiatives, although specific timelines are not detailed in the bill. The potential impacts include improved health outcomes for mothers and infants, increased awareness and informed consent among participants, and a more robust body of research addressing the unique health needs of pregnant and lactating women.
Detailed Analysis
Section 1
Summary
Individuals
Impact
The bill aims to promote the inclusion of pregnant and lactating women in clinical research, which directly affects these individuals by ensuring their health needs are considered in medical studies. This inclusion could lead to better health outcomes for both mothers and infants.
Constitutional Rights
Affected
- Right to health care
- Right to informed consent
- Right to participate in research
Powers
The bill empowers the Secretary of Health and Human Services to create regulations that harmonize existing laws regarding the protection of pregnant women in research.
Constitutional Concerns
Support
The bill supports the constitutional right to health care by potentially improving medical research outcomes for a vulnerable population.
Concerns
There may be concerns regarding the adequacy of protections for pregnant women in research, particularly regarding informed consent and the potential for coercion in participation.
Key Points
Regulatory Updates
The bill mandates updates to FDA regulations to ensure pregnant women are included in clinical trials, which could enhance their rights to participate in research.
Education Campaign
An education campaign will be established to inform pregnant and lactating women about their options in clinical research, promoting informed consent.
Research Prioritization
The establishment of a prioritization process for research on drugs affecting pregnant and lactating women aims to address gaps in medical knowledge, potentially improving health outcomes.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 8651 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
May 4, 2026
Bill Introduced
Current
Introduced
June 18, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat